Michael D. Hooven
President and CEO
Mike Hooven has over 30 years of experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 100 issued and pending US patents.
Mike is the founder, and a Director of AtriCure, Inc. (Nasdaq ATRC). AtriCure is a Medical Device company that manufactures and sells surgical devices to treat the most serious forms of atrial fibrillation. AtriCure has grown rapidly to become the market leader, with over 200,000 procedures performed. AtriCure completed a successful Initial Public Offering on August 5, 2005, and currently lists on the NASDAQ under the symbol ATRC as over $1BB market cap. Mike also is a Director and past Chairman of BioOhio, a state-funded organization to accelerate life-science start-up companies in Ohio. Mike was recently appointed by the Governor to the Third Frontier Advisory Board, a $2.3BB state funded initiative to accelerate high tech job creation in Ohio. Mike also sits on the Commercial Advisory Committee for the University of Cincinnati.
Mike previously held positions as the Chairman and CEO of AtriCure, and the Founder and Chairman of Enable Medical, a surgical device manufacturer that was acquired by AtriCure in August of 2005. Mike founded Enable in April of 1994, and prior to that he headed up all internal product development at Ethicon Endo-Surgery from 1988 to 1994. Mike held Engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. He earned a BS in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.
Andrew S. Eibling, CSAP
Vice President, Business Development and Alliance Management
Andy Eibling is a 30-year veteran of the pharmaceutical industry and an accomplished Alliance Management and Business Development leader with experience in technology, development, commercialization and supplier relationships. Andy joined Enable Injections in 2018 as Vice President of Business Development and Alliance Management, responsible for establishing and maintaining strategic alliances with biopharma partners leveraging the novel wearable drug delivery system developed by Enable.
He was formerly Vice President of Enterprise Alliance Management at Covance, Inc., the drug development division of LabCorp. Prior to joining Covance, Andy spent over 24 years at Eli Lilly and Company, most recently implementing Lilly’s partnering strategy with roles in Business Development.
Andy earned a Bachelor of Science in Mechanical Engineering from Purdue University and a Master of Business Administration from Indiana University.
Executive Vice President and Chief Financial Officer
Tim Flaherty has more than 25 years of public and private company experience in finance, accounting, human resource, and information technology management. At Enable Injections, he is responsible for the finance, accounting, and information technology. Prior to Enable Injections, Tim served as North American CFO for Bonfiglioli, Inc., a leading billion-dollar global Italian owned company in the power transmission market. Tim was nominated for CFO of the year in 2014 by the Cincinnati Business Courier in the large private company category for his achievements at Bonfiglioli, Inc.
Prior to Bonfiglioli, Tim held several executive financial roles in large publicly traded companies and small private companies, including ArvinMeritor (NYSE:ARM), Ametek (NYSE:AME), and AtriCure /Enable Medical (NASD: ATRC), with experience in Merger and Acquisitions, IPO experience, plant consolidations, shared-service operations, multi-location oversight, SEC Reporting, system implementations, scalability, cost and risk controls, and forecasting and strategy. Tim earned his accounting degree from the University of Kentucky and his Master of Business Administration from Xavier University, Cincinnati, OH.
Matthew J. Huddleston
Executive Vice President and Chief Technology Officer
Mr. Matthew J. Huddleston serves as Executive Vice President and Chief Technology Officer for Enable Injections. He is an experienced medical device professional with more than 20 years of experience in startup environments with emphasis in project management, design, development, manufacturing, regulatory, and intellectual property. He has several issued and pending patents in the medical device field, including soft tissue and cardiovascular fixation devices and delivery instruments, histologic automated embedding systems, laparoscopic visualization devices, and automatic injection devices. He is a professional engineer and a licensed patent agent. Matt holds a Bachelor of Science in Mechanical Engineering from Purdue University and a Master of Science in Biomedical Engineering from The Ohio State University.
Tiffany Khodadad, MPH
Vice President, Human Resources
Tiffany Khodadad has over 20 years of pharmaceutical experience in operations, regulatory affairs, human resources, and strategic planning and change management. Tiffany joined Enable in 2016 and has been instrumental in its growth. Prior to joining Enable, Tiffany formerly worked with Cincinnati Children’s Hospital Medical Center, Medpace, a global CRO, and a niche pharmaceutical company. Tiffany earned her bachelor’s at The Ohio State University and master’s at New York University.
John F. Love
Vice President of Product Development and Operations
John has over 30 years of leadership, R&D, and Operations experience in the medical device industry that include the specialty product areas of peritoneal dialysis, mechanical stapling devices, coronary artery brachytherapy, drug eluting stents, endovascular aortic stent repair, and spinal implant systems. Prior to joining Enable, John was the Vice President of Operations at Triangle Manufacturing in New Jersey where he directed a 240-person medical device CNC contract manufacturing facility. From 2007-2016, John held the positions of Corporate Vice President of R&D and Operations, Corporate Vice President of R&D, Quality, Regulatory and Medical Scientific Affairs, and Vice President of Research and Development at Aesculap Implant Systems based in Pennsylvania. Prior to Aesculap, John was the Vice President of Engineering at The MedTech Group, a plastics injection molding company in New Jersey. John has also held leadership and management positions at the following companies: Datascope Intervascular, JFL & Associates, Cordis Corporation, Novoste Corporation, Ethicon Endo Surgery, and Baxter Laboratories. John holds a Bachelor of Science in Biomedical Engineering from the University of Illinois, Chicago and a Master of Engineering Management from Northwestern University.
Vice President of Program Management and Human Factors
Eileen has more than 25 years of experience in the life sciences industry. A majority of her career has focused on biopharmaceutical manufacturing of sterile products in compliance with the FDA’s Code of Federal Regulations as well as ISO and ICH guidelines to meet global regulatory needs. Eileen filled various management roles in Validation, Engineering and Capital Expansion while working for both Stryker Biotech and Amylin Pharmaceuticals. As the Senior Director of Operations at Amylin, Eileen led a cross functional team in the development and approval of an innovative drug delivery system for a sterile injectable product. Currently, Eileen is the Vice President of Program Management and Human Factors at Enable Injections championing device and instructional design with a focus on user needs, usability requirements and minimizing use errors. Eileen also serves as the key liaison for drug partnerships throughout the life cycle of the collaboration, oversees the integration and progress of major milestones in various project teams and ensures communication with all stakeholders. Eileen received her Bachelor of Science degree in Civil Engineering from Drexel University and a Masters degree in Engineering Management from the Thayer School of Engineering at Dartmouth College.
Vice President, Administration
Susan Spies, Vice President of Administration, has over 20 years of experience in start-up biotechnology and life sciences industries. Sue was one of the first employees of Enable Injections, and built the human resources, IT, investor relations and finance departments. She was also responsible for establishing the infrastructure of the human resources, finance, and IT departments at Enable Medical Corporation and AtriCure, Inc. Sue has played an integral part in each start-up company by supporting employee growth, managing the finances, and providing an excellent corporate culture. In earlier years, she worked as a senior IT analyst for Baxter and Cordis Corporation supporting their financial systems. Susan earned her B.S. in Accounting from the University of Delaware and an M.S. in Management Information Systems from the University of Miami.
Dominick C. Villani III
Vice President of Quality / Regulatory Affairs
Dominick Villani has more than 20 years of experience in the Biotechnology, Vaccine, Pharmaceuticals (Sterile and Non-Sterile), and Medical Device sector, responsible for defining, building, and managing requirements within Manufacturing, Quality Control, Quality Assurance, and Regulatory Affairs with multiple companies, including Amgen, Amylin, AstraZeneca, Bristol-Myers Squibb, and Bioport. Dominick joined Enable Injections in 2016 and is a member of the International Organization for Standardization (ISO) for needle-based injections systems and on-body delivery systems. Dominick studied general Biological Sciences, with an emphasis in Microbiology, at the California Lutheran University in Thousand Oaks, California.